Investigators of this study found immediate treatment of early rheumatoid arthritis with tocilizumab alone or with methotrexate to achieve readmission is more effective than the standard methotrexate ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Tocilizumab (Actemra/RoActemra) was not found to have any clear role as a treatment for COVID-19 in ...

The Appraisal Committee considered evidence submitted by the manufacturer of tocilizumab and a review of this submission by the Evidence Review Group (ERG). The manufacturer submitted evidence for the ...

Tocilizumab, a repurposed rheumatoid arthritis drug once considered a promising treatment for hospitalized patients with Covid-19, generally did not increase patients’ chances of survival or help them ...

Tocilizumab (TCZ) is one of multiple drugs that have been studied in clinical trials around the world as a potential treatment for COVID-19. A team of international researchers present their results ...

Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. A California pulmonary disease specialist has voiced promise in tocilizumab drug treatment for critically ...

Please provide your email address to receive an email when new articles are posted on . Tocilizumab plus prednisone was linked to a sixfold reduced risk for treatment failure in patients with giant ...

Respiratory.ventilation The sBLA is supported by data from 4 randomized, controlled studies that evaluated tocilizumab for the treatment of COVID-19 in more than 5500 hospitalized patients. The Food ...

A phase 3 study of tocilizumab (Actemra®) for the treatment of hospitalized patients with severe COVID-19 pneumonia did not meet its primary and key secondary end points. Genentech announced that a ...